• SENSEX 80,568.81
    28.90 (+0.04%)
  • BANKNIFTY 55,181.45
    137.75 (+0.25%)
  • Authum Invest
    2,496.00 1,333.00(%)
  • N S D L
    1,161.50 880.00(%)
  • Adani Energy Sol
    775.65 588.25(%)
  • Muthoot Finance
    2,799.00 2,717.00(%)
  • Zinka Logistics
    525.00 248.25(%)
  • HBL Engineering
    787.50 779.00(%)
  • Newgen Software
    929.00 1,795.50(%)
  • Waaree Energies
    2,833.50 1,808.65(%)
  • Ola Electric
    43.00 157.53(%)
  • Vishal Mega Mart
    155.45 149.10(%)
  • Reliance Industr
    1,372.65 1,115.55(%)
  • Kotak Mah. Bank
    1,975.60 1,679.10(%)
  • ICICI Bank
    1,430.85 1,494.10(%)
  • Anthem Bioscienc
    825.00 801.75(%)
  • TCS
    3,021.00 2,992.05(%)
  • Suzlon Energy
    60.00 46.00(%)
  • HCL Technologies
    1,493.80 1,304.00(%)
  • Afcom Holdings
    890.10 1,268.95(%)
  • Vodafone Idea
    6.12 6.30(%)
  • Manappuram Fin.
    267.75 285.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
359.70 7 (1.98%)
  • As on 14 Aug 2025 (EOD)

  • Today’s Low

    359.70

  • Today’s High

    359.75

  • Open

    359.75

  • Perv Close

    352.70

  • 52W Low

    219.00

  • 52W High

    449.00

Key Indicators

  • P/E(TTM)

    11.93

  • Mar.Cap (₹Cr.)

    1,058.63

  • Div & Yield %

    0.69

  • Book Value(₹)

    129.14

  • Debt-Equity Ratio

    1.98

  • AGM Date

    13-Aug-2025

  • EPS

    30.14

  • P/E Ratio

    11.93

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    1,058.63

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    129.10

  • Sales( ₹ in Cr.)

    430.53

  • NP (in Cr.)

    71.70

  • NP Var(%)

    1027.0

  • Div%

    50.0

  • CPS (₹)

    32.20

  • EPS (₹)

    24.40

  • Traded Value (₹ in Lakhs)

    1,058.63

  • 52 Week High

    449.00

  • 52 Week Low

    219.00

  • Price BSE

    360.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,058.63

  • P/C Ratio

    11.20

  • P/E Ratio

    14.80

  • Price Vs.BV

    24.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 430.53 307.09 328.91 387.96 372.82 300.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 1.24
Net Sales 430.53 307.09 328.91 387.96 372.82 299.27
Other Income 11.68 8.15 8.46 7.53 6.62 12.31
Stock Adjustments 7.59 -13.86 -17.29 -7.65 15.88 20.79
Total Income 449.80 301.38 320.08 387.84 395.32 332.37
EXPENDITURE :            
Raw Materials 146.22 91.57 109.21 136.55 139.52 103.46
Power and Fuel Cost 27.23 19.78 18.24 20.35 14.23 12.74
Employee Cost 60.10 53.93 53.81 59.36 57.50 50.03
Other Manufacturing Expenses 57.00 50.29 44.12 43.65 36.06 27.85
Selling and Administration Expenses 39.08 34.46 38.73 38.16 37.25 47.28
Miscellaneous Expenses 7.74 14.87 68.12 5.42 9.41 8.25
Employee Benefit Expenses 60.10 53.93 53.81 59.36 57.50 50.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 337.37 264.90 332.23 303.50 293.96 249.61
Operating Profit 112.43 36.49 -12.14 84.35 101.36 82.75
Interest 14.84 17.40 21.35 18.11 19.10 20.27
Gross Profit 97.59 19.09 -33.49 66.24 82.26 62.48
Depreciation 23.17 23.70 24.49 23.67 19.03 14.94
Profit Before Tax 74.42 -4.61 -57.98 42.57 63.23 47.54
Current Tax 13.12 14.14 -0.97 7.41 11.26 3.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.32 0.00 0.00 4.92 0.00 -19.49
Reported Net Profit 67.62 -18.74 -57.00 30.24 51.97 63.67
Extraordinary Items -4.09 -11.01 -60.09 -0.02 -0.13 1.90
Adjusted Net Profit 71.71 -7.73 3.09 30.26 52.10 61.77
Adjustment below Net Profit -0.80 0.12 9.52 -0.24 -0.04 -6.22
P & L Balance brought forward 276.80 299.03 350.72 327.93 275.99 218.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.61 3.61 4.20 7.21 0.00 0.00
P & L Balance carried down 340.00 276.80 299.03 350.72 327.93 275.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 25.00 25.00 25.00 50.00 100.00
Dividend Per Share(Rs) 2.50 1.25 1.25 1.25 2.50 5.00
Earnings Per Share-Unit Curr 23.18 -6.49 -19.75 10.48 18.01 22.07
Earnings Per Share(Adj)-Unit Curr 23.18 -6.49 -19.75 10.48 18.01 22.07
Book Value 130.26 108.83 116.45 137.26 128.42 108.36
Book Value(Adj)-Unit Curr 130.26 108.83 116.45 137.26 128.42 108.36

Shareholding Pattern

  • Promoter Group

    64.09%

  • Public Share Holding

    35.02%

  • Custodian

    0.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,298 0.02 7,298 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,418 0.03 7,418 3
2] Non Institution
Bodies Corporate 549,844 1.87 549,244 108
Clearing Members 2,995 0.01 2,995 2
Directors of their Relatives 139,410 0.47 139,410 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 272,726 0.93 272,726 321
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 289,383 0.98 289,383 396
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,049,994 10.36 3,049,994 22
Individuals holding nominal share capital up to Rs. 1 lakh 5,661,245 19.24 5,451,150 11,969
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 124,800 0.42 124,800 2
Others 190,497 0.65 190,497 3
Sub Total 10,300,549 35.00 10,089,854 12,837
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 262,011 0.89 262,011 1
Total Shares held by Custodians and against which Depository Receipts have been issued 262,011 0.89 262,011 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,220,292 12,845

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

    Srikant N Sharma

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 359.70 442.21 430.53 11.93 17.61
Abbott India 32,986.65 6,684.73 6,409.15 48.27 44.95
Astrazeneca Phar 8,417.20 1,756.92 1,716.29 181.80 32.94
P & G Health Ltd 6,180.70 944.52 934.17 34.13 40.23
Glaxosmi. Pharma 2,773.70 3,866.05 3,723.49 49.88 58.72
Cipla 1,561.85 20,029.57 19,044.85 23.34 21.40
Novartis India 950.75 398.23 356.27 22.84 16.64
Amrutanjan Healt 681.85 437.58 421.23 38.79 20.84
Guj. Themis Bio. 364.85 174.19 169.82 89.21 44.82
Bliss GVS Pharma 170.70 703.42 667.20 25.52 9.16
Ambalal Sarabhai 32.70 19.33 4.04 30.28 2.10